Malignancy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Histological or cytological diagnosis of non-small-cell lung cancer at primary site (2) Follow-up or predicting anticancer therapy (3) More than 3 months' life expectancy prognosis (4) ECOG performance status 0-2 (5) Ability to communicate and write in Japanese (6) Written informed consent by patient
Exclusion criteria
Exclusion criteria: (1) Disturbance of consciousness (2) Severe physical disorder such as pain, dyspnea, fatigue, nause, or vomiting (3) Severe mental disorder such as delirium and dementia (4) Participation in other trial (5) Patients incapable of completing this study as determined by the primary physician or investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is face and content validity, and efficacy of the orientation program | — |
Secondary
| Measure | Time frame |
|---|---|
| Scores on the following measures: The Consultation and Relational Empathy (CARE) Measure Decision Conflict Scale (DCS) Patient Health Questionnaire-9 (PHQ-9) | — |
Countries
Japan
Contacts
National Cancer Center Hospital East department of Psycho-Oncology Service